v3.8.0.1
Concentration of Risk
 12 Months Ended
Nov. 30, 2017
Risks and Uncertainties [Abstract]  
CONCENTRATION OF RISK CONCENTRATION OF RISK
Most of the Company’s products are sold to major drug and food chains merchandisers, and wholesale beauty-aids distributors throughout the United States and Canada.
During the fiscal years ended November 30, 2017, 2016 and 2015, certain customers each accounted for more than 5% of the Company’s net sales, as follows:
 
 
 
For the Year Ended November 30,
Customer
 
2017
 
2016
 
2015
Walmart
 
36.3
%
 
38.7
%
 
34.6
%
Walgreens
 
13.4
%
 
10.5
%
 
13.4
%
Target
 
6.9
%
 
8.6
%
 
7.2
%
CVS
 
*

 
*

 
5.7
%
Foreign Sales
 
12.4
%
 
11.3
%
 
13.2
%

 
*
less than 5%

The loss of any one of these customers could have a material adverse effect on the Company’s earnings and financial position.
During the fiscal years November 30, 2017, 2016 and 2015, certain products within the Company’s product lines accounted for more than 10% of the Company’s net sales as follows: 
 
 
For the Year Ended November 30,
Category
 
2017
 
2016
 
2015
Skin Care
 
52.6
%
 
54.0
%
 
51.9
%
Oral Care
 
37.8
%
 
38.7
%
 
34.4
%